Azitra Inc (AZTR)

US · Healthcare · Biotechnology

$0.070.00%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.3M

EPS

$-0.17

EPS estimate

$-0.21

EPS came in at -0.17 against a street estimate of -0.21 — a beat of 19.0%.

Market cap

$4.3M

Forward P/E

0.0

P/B

1.37

Book value

$0.12

EPS (TTM)

$-0.17

52-week high

$1.09

52-week low

$0.05

50-day MA

$0.15

200-day MA

$0.20

Beta

-1.04

Analysts rate Azitra Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $0.67.

Insiders

7.59%

Institutions

32.04%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Azitra Inc — free to start.

Data updated 2026-10-19.